Hyperaemic effects of adenosine and dobutamine in heart failure with reduced ejection fraction: A quantitative perfusion CMR study

Clicks: 2
ID: 321346
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #2 of 47 articles by views in European Heart Journal - Imaging Methods and Practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Aims In patients with heart failure with reduced ejection fraction (HFrEF), determining the aetiology of cardiac dysfunction has important therapeutic and prognostic implications. Cardiovascular magnetic resonance (CMR) enables comprehensive phenotyping of HFrEF; however, it remains uncertain whether the choice of pharmacological stress agent influences the hyperaemic response required for reliable ischaemia assessment. We sought to compare the hyperaemic effects of adenosine and dobutamine in patients with HFrEF using quantitative perfusion CMR. Methods and results Patients with HFrEF (left ventricular ejection fraction [LVEF] ≤ 40%) prospectively underwent 3-Tesla CMR comprising functional cine imaging, late gadolinium enhancement (LGE) and first-pass perfusion imaging at rest and during pharmacological stress with (1) adenosine [140-210μg/kg/min] and (2) dobutamine [10-30 µg/kg/min]. Perfusion maps were reconstructed inline with automated, pixel-wise quantification of myocardial blood flow (MBF). The hyperaemic response, defined by global myocardial perfusion reserve (MPR) was calculated as the quotient of stress and rest MBF and compared between stress protocols. Fifty-three patients with HFrEF (mean age 63 ± 10 years, 77% male, mean LVEF 36 ± 10%, infarction 59%, and non-ischaemic focal fibrosis 21%) with paired adenosine- and dobutamine-stress perfusion data were analysed. Compared with dobutamine, adenosine produced a higher global MPR (mean difference: +0.61 [95% CI: 0.35, 0.88], p < 0.001), which remained significant at the segmental level following adjustment for age, sex, type II diabetes, LVEF and LGE presence (mean difference: +0.63 [95% CI: 0.55, 0.71]; p < 0.001). Conclusions In patients with HFrEF, despite the greater haemodynamic response to dobutamine, adenosine induces a greater hyperaemic response; however, whether this impacts on the diagnostic assessment of ischaemia remains to be established (Trial registration: NCT03661827).
Reference Key
openalex_W7169159040 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Simran Shergill, A Khedr Abdelaty, Sunny R Sedani, Aida Moafi, Lavanya Athithan, Joanna M Bilak, Mohamed Elshibly, Iyare Nehikhare, Adeogo Akinwale Olusan, P Jaspal, Simon Hetherington, Mohamed Nabil Alama, Peter Kellman, David Adlam, Eylem Levelt, Anvesha Singh, Iain B Squire, Sandeep S Hothi, Jeffrey Khoo, Gaurav S Gulsin, Gerry P McCann, J Ranjit Arnold
Journal European Heart Journal - Imaging Methods and Practice
Year 2026
DOI
10.1093/ehjimp/qyag128
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.